Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson's disease

Anesthesia and Analgesia

Volumn 103, Issue 5, 2006, Pages 1224-1228

  Rozet, Irene ^a,c   Muangman, Saipin ^a   Vavilala, Monica S ^a,b   Lee, Lorri A ^a,b   Souter, Michael J ^a,b   Domino, Karen J ^a,b   Slimp, Jefferson C ^b   Goodkin, Robert ^b   Lam, Arthur M ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE;

ADULT; AGED; ANESTHESIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN MAPPING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROPHYSIOLOGY; FEMALE; HEMODYNAMICS; HUMAN; IMPLANTATION; MALE; MEDICAL RECORD REVIEW; PARKINSON DISEASE; PATIENT SATISFACTION; PRIORITY JOURNAL; SEDATION;

AGED; BLOOD PRESSURE; DEEP BRAIN STIMULATION; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES;

EID: 33750285490     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000239331.53085.94     Document Type: Article

References (16)

1. Deep-brain stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus of the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-63.
2. Binder DK, Rau GF, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005;56:722-32.
3. Alkhani A, Lozano AM. Pallidotomy for Parkinson disease: A review of contemporary literature. J Neurosurg 2001;94:43-9.
4. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-34.
5. Gorgulho A, De Salles AAF, Frighetto L, Behnke E. Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. J Neurosurg 2005;102:888-96.
6. Hsu YW, Cortinez LI, Robertson KM, et al. Part I: Dexmedetomidine pharmacodynamics. Anesthesiology 2004;101:1066-76.
7. Chernik DA, Gillings D, Lane H, et al. Validity and reliability of the observer's assessment of alertness/sedation scale: Study with intravenous midazolam. J Clin Psychopharmacol 1990;10:244-51.
8. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94.
9. Ard J, Doyle W, Bekker A. Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol 2003;15:263-6.
10. Ard J, Doyle W, Bekker A. Dexmedetomidine in awake craniotomy: A technical note. Surg Neurol 2005;63:114-7.
11. Bekker A, Kaufman B, Samir H, Doyle W. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg 2001;92:1251-3.
12. Fogarty-Mack P, Perrine K, Kobylarz E, et al. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol 2004;16:20-5.
13. Bustillo LM, Lazar RM, Finck AD, et al. Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: A retrospective case report series. J Neurosurg Anesthesiol 2002;14:209-12.
14. Ramsey MA, Luterman DL. Dexmedetomidine as a total intravenous anesthestic agent. Anesthesiology 2004;101:787-90.
15. Stone JG, Schwartz AE, Berman MF, et al. Air embolization in seated, sedated, spontaneously breathing, neurosurgical patients. Anesthesiology 1997;87:1244-7.
16. Long AE, Lozano AM. Parkinson's disease. N Engl J Med 1996;334:71-6.